March 4 () - PepGen said on Wednesday that the U. Food and Drug Administration has placed ‌a partial clinical hold on its mid‑stage trial of ‌a rare muscle disease drug, sending its shares plunging ...
Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants
The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who ...
The FDA’s effort to crack down on compounded versions of popular GLP-1 weight-loss drugs has sparked backlash from patients and compounding pharmacies over concerns about access and ...
The FDA has issued 30 warning letters to telehealth companies over misleading claims about compounded GLP-1 drugs. Regulators say some companies im ...
March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...
The U.S. Food and Drug Administration's (FDA) chief says the agency will begin offering bonuses to drug reviewers who ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...
Over 100 chemicals of unknown safety were secretly added to foods and supplements without notifying the public or the FDA, a new investigation found.
A decades-old warning rooted in flawed research kept millions of women from life-changing treatment, officials say.
Marty Makary appeared for Thursday an interview on CNBC to tout efforts under his leadership at the Food and Drug Administration to speed up approvals for treatments of rare diseases. Instead, he ...
The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete ...
The US Food and Drug Administration plans to give bonuses to scientific staff for speeding up drug reviews, according to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results